Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Pharmaceutica

The Journal of Croatian Pharmaceutical Society

4 Issues per year


IMPACT FACTOR 2016: 1.288
5-year IMPACT FACTOR: 1.600

CiteScore 2016: 1.55

SCImago Journal Rank (SJR) 2016: 0.353
Source Normalized Impact per Paper (SNIP) 2016: 0.854

Open Access
Online
ISSN
1846-9558
See all formats and pricing
More options …
Volume 63, Issue 4 (Dec 2013)

Issues

Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs

Katja Čerpnjak / Alenka Zvonar / Mirjana Gašperlin / Franc Vrečer
  • Krka, d.d., Novo mesto, 8501 Novo mesto, Slovenia
  • Fakulteta za farmacijo, 1000 Ljubljana,Slovenia
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2013-12-31 | DOI: https://doi.org/10.2478/acph-2013-0040

Abstract

Low oral bioavailability as a consequence of low water solubility of drugs is a growing challenge to the development of new pharmaceutical products. One of the most popular approaches of oral bioavailability and solubility enhancement is the utilization of lipid-based drug delivery systems. Their use in product development is growing due to the versatility of pharmaceutical lipid excipients and drug formulations, and their compatibility with liquid, semi-solid, and solid dosage forms. Lipid formulations, such as self-emulsifying (SEDDS), self-microemulsifying SMEDDS) and self- -nanoemulsifying drug delivery systems (SNEDDS) were explored in many studies as an efficient approach for improving the bioavailability and dissolution rate of poorly water-soluble drugs. One of the greatest advantages of incorporating poorly soluble drugs into such formulations is their spontaneous emulsification and formation of an emulsion, microemulsion or nanoemulsion in aqueous media. This review article focuses on the following topics. First, it presents a classification overview of lipid-based drug delivery systems and mechanisms involved in improving the solubility and bioavailability of poorly water-soluble drugs. Second, the article reviews components of lipid-based drug delivery systems for oral use with their characteristics. Third, it brings a detailed description of SEDDS, SMEDDS and SNEDDS, which are very often misused in literature, with special emphasis on the comparison between microemulsions and nanoemulsions.

Keywords: lipid-based drug delivery systems (LBDDS); self-emulsifying drug delivery systems (SEDDS); self-microemulsifying drug delivery systems (SMEDDS); self-nanoemulsifying drug delivery systems (SNEDDS); microemulsions; nanoemulsions

  • 1. J. M. Custodio, C. Y. Wu and L. Z. Benet, Predicting drug disposition, absorption/elimination/ transporter interplay and the role of food on drug absorption, Adv. Drug Deliver. Rev. 60 (2008) 717-733; DOI: 10.1016/j.addr.2007.08.043.CrossrefGoogle Scholar

  • 2. A. Chaudhary, U. Nagaich, N. Gulati, V. K. Sharma and R. L. Khosa, Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: A recent review, J. Adv. Pharm. Educ. Res. 2 (2012) 32-67.Google Scholar

  • 3. K. Kohli, S. Chopra, D. Dhar, S. Arora and R. K. Khar, Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability, Drug Discov. Today 15 (2010) 958-965; DOI: 10.1016/ j.drudis.2010.08.007.CrossrefGoogle Scholar

  • 4. Y. Kawabata, K. Wada, M. Nakatani, S. Yamada and S. Onoue, Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications, Int. J. Pharm. 420 (2011) 1-10; DOI: 10.1016/j.ijpharm.2011.08.032.CrossrefGoogle Scholar

  • 5. T. Loftsson, E. M. Brewater and M. Masson, Role of cyclodextrins in improving oral drug delivery, Am. J. Drug Deliv. 2 (2004) 261-275; DOI: 10.2165/00137696-200402040-00006.CrossrefGoogle Scholar

  • 6. S. B. Murdandea and M. J. Gumkowskia, Development of a self-emulsifying formulation that reduces the food effect for torcetrapib: An overview, Int. J. Pharm. 51 (2008) 15-22; DOI: 10. 1016/j.ijpharm.2007.09.015.CrossrefGoogle Scholar

  • 7. J. Parul, A. Geeta and K. Amanpreet, Bioavailability enhancement of poorly soluble drugs by SMEDDS: A review, J. Drug Deliv. Ther. 3 (2013) 98-109.Google Scholar

  • 8. S. Saroy, D. A. Baby and M. Sabitha, Current trends in lipid based delivery systems and its applications in drug delivery, Asian J. Pharm. Clin. Res. 5 (2012) 4-9.Google Scholar

  • 9. H. J. C. Porter, L. N. Trevaskis and W. N. Charman, Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs, Nat. Rev. Drug Discov. 6 (2007) 231-248; DOI: 10. 1038/nrd2197.CrossrefGoogle Scholar

  • 10. B. K. Nanjwade, D. J. Patel, R. A. Udhani and F. V. Manvi, Function of lipids for enhancement of oral bioavailability of poorly water-soluble drugs, Sci. Pharm. 79 (2011) 705-727; DOI: 10.3797/ scipharm.1105-09.CrossrefGoogle Scholar

  • 11. W. C. Pouton and J. H. C. Porter, Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies, Adv. Drug Deliver. Rev. 60 (2008) 625-637; DOI: 10. 1016/j.addr.2007.10.010.CrossrefGoogle Scholar

  • 12. W. C. Pouton, Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system, Eur. J. Pharm. Sci. 29 (2006) 278-287; DOI: 10.1016/j.ejps.2006.04.016.CrossrefGoogle Scholar

  • 13. V. Jannin, J. Musakhanian and D. Marchaud, Approaches for the development of solid and semi-solid lipid-based formulations, Adv. Drug Deliver. Rev. 60 (2008) 734-746; DOI: 10.1016/j. addr.2007.09.006.CrossrefGoogle Scholar

  • 14. B. V. Rajesh, T. K. Reddy, G. Srikanth, V. Mallikarjun and P. Nivethithai, Lipid based self-emulsifying drug delivery system (SEDDS) for poorly water-soluble drugs: A review, J. Glob. Pharma Technol. 2 (2010) 47-55.Google Scholar

  • 15. R. N. Gupta, R. Gupta and R. G. Singh, Enhancement of oral bioavailability of lipophilic drugs from self-microemulsifying drug delivery systems (SMEDDS), Int. J. Drug Dev. Res. 1 (2009) 10-18.Google Scholar

  • 16. K. Mohsin, A. A. Shahba and F. K. Alanazi, Lipid based self-emulsifying formulations for poorly water soluble drugs- an excellent opportunity, Ind. J. Pharm. Edu. Res. 46 (2012) 88-96.Google Scholar

  • 17. P. Gao and W. Morozowich, Development of supersaturatable self-emulsifying drug delivery system formulation for improving the oral absorption of poorly soluble drugs, Expert Opin. Drug Del. 3 (2006) 97-110; DOI: 10.1517/17425247.3.1.97.CrossrefGoogle Scholar

  • 18. B. D. Tarr and S. H. Yalkowsky, Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size, Pharm. Res. 6 (1989), 40-43; DOI: 10.1023/A:10158435 17762.CrossrefGoogle Scholar

  • 19. B. Singh, S. Bandopadhyay, R. Kapil, R. Singh and O. Katare, Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications, Crit. Rev. Ther. Drug 26 (2009) 427-521.CrossrefGoogle Scholar

  • 20. J. H. Lin, W. Chen and J. King, The effect of dosage form on oral absorption of L-365, 260, a potent CCK receptor antagonist in dogs, Pharm. Res. 8 (1991) 272.Google Scholar

  • 21. M. J. Groves and D. A. Degalindez, The self-emulsifying action of mixed surfactants in oil, Acta Pharm. Suec. 13 (1976) 361-372.Google Scholar

  • 22. S. M. Khoo, A. J. Humberstone, C. J. H. Porter, G. A. Edwards and W. N. Charman, Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine, Int. J. Pharm. 167 (1998) 155-164; DOI: 10.1016/S0378-5173(98)00054-4.CrossrefGoogle Scholar

  • 23. K. J. Palin and C. G. Wilson, The effect of different oils on the absorption of probucol in the rat, J. Pharm. Pharmacol. 36 (1984) 641-643; DOI: 10.1111/j.2042-7158.1984.tb04919.CrossrefGoogle Scholar

  • 24. J. Rao and D. J. McClements, Formation of flavor oil microemulsions, nanoemulsions and emulsions: influence of composition and preparation method, J. Agric. Food Chem. 59 (2011) 5026-5035; DOI: 10.1021/jf200094m.CrossrefGoogle Scholar

  • 25. M. Stuchlik and S. @ák, Lipid-based vehicle for oral drug delivery, Biomed. Pap. 145 (2001) 17-26.CrossrefGoogle Scholar

  • 26. P. Constantinides, Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects, Pharm. Res. 12 (1995) 1561-1572; DOI: 10.1023/A: 1016268311867.CrossrefGoogle Scholar

  • 27. M. Kimura, M. Shizuki, K. Miyoshi, T. Sakai, H. Hidaka, H. Takamura and T. Matoba, Relationship between the molecular structures and emulsification properties of edible oils, Biosci. Biotech. Bioch. 58 (1994) 1258-1261; DOI: 10.1271/bbb.58.1258. CrossrefGoogle Scholar

  • 28. M. Grovea and A. Mullertzb, Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides, Eur. J. Pharm. Sci. 28 (2006) 233-234; DOI: 10.1016/j.ejps.2006.02.005.CrossrefGoogle Scholar

  • 29. C. J. Porter, A. M. Kaukonen and B. J. Boyd, Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation, Pharm. Res. 8 (2004) 1405-1412; DOI: 10.1023/B:PHAM.0000036914.22132.cc.CrossrefGoogle Scholar

  • 30. H. N. Prajapati, M. D. Dalrymple and T. M. A. Serajuddin, A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development, Pharm. Res. 29 (2012) 285-305; DOI: 10.1007/s11095-011-0541-3.CrossrefGoogle Scholar

  • 31. K. Bolko, A. Zvonar and M. Ga{perlin, Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility, Drug Dev. Ind. Pharm. 2013, in press; DOI: 10.3109/03639045. 2012.749888.CrossrefGoogle Scholar

  • 32. P. P. Constantinides and J. P. Scalart, Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides, Int. J. Pharm. 158 (1997) 57-68; DOI: 10.1016/S0378-5173(97)00248-2.CrossrefGoogle Scholar

  • 33. D. M. Small, Surface and bulk interactions of lipids and water with a classification of biologically active lipids based on these interactions, Fed. Proc. 29 (1970) 1320-1326.Google Scholar

  • 34. W. C. Pouton, Properties and uses of common formulation lipids, surfactants and cosolvents, in AAPS, Workshop, March 2007.Google Scholar

  • 35. N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld and A. W. Malick, Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, Int. J. Pharm. 106 (1994) 15-23.CrossrefGoogle Scholar

  • 36. Pharmaceutical Excipients, Product Reference Quick Guide, Gattefosse, Version VIII, April 2012; http://www.drug-dev.com/Media/MarketPlaceMedia/2012%20GUSA%20PHARMA%20EXCIPIENT %20GUIDE%204.16.12.pdf; access date December 12, 2012.Google Scholar

  • 37. J. B. Cannon, Strategies to formulate lipid-based drug delivery systems, Am. Pharm. Rev. 14 (2011) 4.Google Scholar

  • 38. A. Zvonar, M. Ga{perlin and J. Kristl, Samo(mikro)emulgirajo~i sistemi - alternativen pristop za izbol{anje biolo{ke uporabnosti lipofilnih u~inkovin = Self(micro)emulsifying systems - alternative approach for improving bioavailability of lipophilic drugs, Farm. Vestn. 59 (2008), 263-268.Google Scholar

  • 39. S. Charman, Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound, Pharm. Res. 9 (1992) 87-93; DOI: 10.1023/A: 1018987928936.CrossrefGoogle Scholar

  • 40. R. Neslihan Gursoy and S. Benita, Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs, Biomed. Pharmacother. 58 (2004) 173-182; DOI: 10.1016/j. biopha.2004.02.001.CrossrefGoogle Scholar

  • 41. E. S. Swenson, W. B. Milisen and W. Curatolo, Intestinal permeability enhancement: efficacy, acute local toxicity and reversibility, J. Pharm. Res. 11 (1994) 1132-1142; DOI: 10.1023/A:1018984731584.CrossrefGoogle Scholar

  • 42. T. G. Mason, J. N. Wilking, K. Meleson, C. B. Chang and S. M. Graves, Nanoemulsions: formation, structure and physical properties, J. Phys-Condens. Mat. 18 (2006) 635-666; DOI: 10.1088/ 0953-8984/18/41/R01.CrossrefGoogle Scholar

  • 43. H. D. Oh, H. J. Kang, W. D. Kim, J. B. Lee, O. J. Kim, S. C. Yong and G. H. Choi, Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier, Int. J. Pharm. 420 (2011) 412-418; DOI: 10.1016/j.ijpharm.2011. CrossrefGoogle Scholar

  • 44. K. B. Kang, J. S. Lee and S. K. Chon, Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs, Int. J.Pharm. 274 (2004) 65-73; DOI: 10.1016/j.ijpharm.2003.12.028.CrossrefGoogle Scholar

  • 45. S. Nazzal, I. SmalyukhI, O. D. Lavrentovich and M. A. Khan, Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation, Int. J. Pharm. 235 (2002) 247-65;DOI: 10.1016/S0378-5173(02)00003-0.CrossrefGoogle Scholar

  • 46. C. W. Pouton, Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems, Eur. J. Pharm. Sci. 11 (2000) 93-98; DOI: 10.1016/S0928-0987(00)00167-6.CrossrefGoogle Scholar

  • 47. N. Anton and T. F. Vandamme, Nano-emulsions and micro-emulsions: Clarifications of the critical differences, Pharm. Res. 28 (2011) 978-985; DOI: 10.1007/s11095-010-0309-1.CrossrefGoogle Scholar

  • 48. P. K. Suresh and S. Sharma, Formulation and in vitro characterization of self-nanoemulsifying drug delivery system of cinnarizine, Int. J. Compr. Pharm. 2011. ISSN 0976-8157.Google Scholar

  • 49. D. Ghai and V. R. Sinha, Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of the poorly water-soluble selective b1-adrenoreceptor blocker Talinolol, Nanomed.- Nanotechnol. 8 (2012) 618-626; DOI: 10.1016/j.nano.2011.08.015.CrossrefGoogle Scholar

  • 50. S. Tenjarla, Microemulsions: an overview and pharmaceutical applications, Crit. Rev. Ther. Drug. 16 (1999) 461-521.Google Scholar

  • 51. P. V. Chavda, Are SMEDDs and SNEDDs same? A gimmick or pharmaceutically relevant, Mintage J. Pharm. Med. Sci. 1 (2012) 7-10.Google Scholar

  • 52. D. J. McClements and J. Rao, Food-grade nanoemulsions: Formulation, fabrication, properties, performance, biological fate and potential toxicity, Crit. Rev. Food Sci. 51 (2011) 285-330; DOI: 10.1080/10408398.2011.559558.CrossrefGoogle Scholar

  • 53. A. Martin, Physical Pharmacy, 4th ed., Lea&Febriger, London 1993, pp.127-128.Google Scholar

  • 54. H. Araya, M. Tomita and M. Hayashi, The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds, Int. J. Pharm. 305 (2005) 61-74; DOI: 10.1016/j.ijpharm.2002.08.022.CrossrefGoogle Scholar

  • 55. J. M. Lawrence, Microemulsions as drug delivery vehicles, Colloid Interface Sci. 1 (1996) 826-832; DOI: 10.1016/S1359-0294(96)80087-2.CrossrefGoogle Scholar

  • 56. P. Solans, J. Nolla and N. Azemar, Nanoemulsions, Curr. Opin. Colloid In. 10 (2005) 102-110; DOI: 10.1016/j.cocis.2005.06.004.CrossrefGoogle Scholar

  • 57. M. Antonietti and K. Landfester, Polyreactions in miniemulsions, Prog. Polym. Sci. 27 (2002) 689-757; DOI: 10.1016/S0079-6700(01)00051-X.CrossrefGoogle Scholar

  • 58. T. Tadros, P. Izquierdo, J. Esquena and C. Solans, Formation and stability of nanoemulsions, Colloid Interface Sci. 108 (2004) 303-318; DOI: 10.1016/j.cis.2003.10.023.CrossrefGoogle Scholar

  • 59. V. Sadtler, M. Rondon-Gonzales, A. Acrement, A. Choplin and E. Marie, PEO-covered nanoparticles by emulsion. Inversion point (EIP) method, Macromol. Rapid Comm. 31 (2010) 998-1002; DOI: 10.1002/marc.200900835.CrossrefGoogle Scholar

  • 60. I. Sole, A. Maestro, C. Gonzales, C. Solans and J. M. Gutierrez, Optimization of nano-emulsion preparation by low-energy methods in an ionic surfactant system, Langmuir 22 (2006) 8326-8332; DOI: 10.1021/Ia0613676.CrossrefGoogle Scholar

  • 61. P. Shah, D. Bhalodia and P. Shelat, Nanoemulsion: A pharmaceutical review, Syst. Rev. Pharm. 1 (2010) 24-32; DOI: 10.4103/0975-8453.59509.CrossrefGoogle Scholar

  • 62. E. Mohajeri and G. D. Noudeh, Effect of temperature on the critical micelle concentration and micellization thermodynamic of nonionic surfactants: polyoxyethylene sorbitan fatty acid esters, E. J. Chem. 9 (2012) 2268-2274; DOI: 10.1155/2012/961739. CrossrefGoogle Scholar

About the article

Published Online: 2013-12-31

Published in Print: 2013-12-01


Citation Information: Acta Pharmaceutica, ISSN (Online) 1846-9558, ISSN (Print) 1330-0075, DOI: https://doi.org/10.2478/acph-2013-0040.

Export Citation

This content is open access.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Babita Garg, Sarwar Beg, Ranjot Kaur, Rajendra Kumar, Om Prakash Katare, and Bhupinder Singh
Journal of Drug Targeting, 2017, Page 1
[2]
Prashant P. Mande, Sagar S. Bachhav, and Padma V. Devarajan
Asian Journal of Pharmaceutical Sciences, 2017
[3]
Ronak Savla, Jeff Browne, Vincent Plassat, Kishor M. Wasan, and Ellen K. Wasan
Drug Development and Industrial Pharmacy, 2017, Volume 43, Number 11, Page 1743
[4]
Janine Griesser, Stephanie Burtscher, Saskia Köllner, Isabelle Nardin, Felix Prüfert, and Andreas Bernkop-Schnürch
European Journal of Pharmaceutics and Biopharmaceutics, 2017, Volume 119, Page 264
[5]
Kaila P. Medina-Alarcón, Junya L. Singulani, Aline R. Voltan, Janaina C. O. Sardi, Maicon S. Petrônio, Mariana B. Santos, Carlos R. Polaquini, Luis O. Regasini, Vanderlan S. Bolzani, Dulce H. S. da Silva, Marlus Chorilli, Maria J. S. Mendes-Giannini, and Ana M. Fusco-Almeida
Frontiers in Microbiology, 2017, Volume 8
[6]
J. Mandić, A. Zvonar Pobirk, F. Vrečer, and M. Gašperlin
International Journal of Pharmaceutics, 2017
[7]
Shannon P. Callender, Jessica A. Mathews, Katherine Kobernyk, and Shawn D. Wettig
International Journal of Pharmaceutics, 2017, Volume 526, Number 1-2, Page 425
[8]
Harshita Raina, Simrandeep Kaur, and Anil B. Jindal
Journal of Drug Delivery Science and Technology, 2017, Volume 39, Page 180
[9]
Kapilkumar Vithani, Adrian Hawley, Vincent Jannin, Colin Pouton, and Ben J. Boyd
The AAPS Journal, 2017, Volume 19, Number 3, Page 754
[10]
A.-C. Groo, M. De Pascale, A.-S. Voisin-Chiret, S. Corvaisier, M. Since, and A. Malzert-Fréon
European Journal of Pharmaceutical Sciences, 2017, Volume 97, Page 218
[11]
Océane Dubray, Vincent Jannin, Fréderic Demarne, Yann Pellequer, Alf Lamprecht, and Arnaud Béduneau
International Journal of Pharmaceutics, 2016, Volume 515, Number 1-2, Page 293
[12]
Jong-Wan Lee, Nam-Hong Kim, Eun-Ji Kim, Hun Heo, Young Jun Jung, Jung Ro Lee, Yung-Hoon Park, Seong-Cheol Park, and Mi-Kyeong Jang
Biotechnology and Bioprocess Engineering, 2016, Volume 21, Number 4, Page 508
[13]
Emmanuel Omari-Siaw, Qilong Wang, Congyong Sun, Zengquan Gu, Yuan Zhu, Xia Cao, Caleb Kesse Firempong, Rita Agyare, Ximing Xu, and Jiangnan Yu
International Journal of Pharmaceutics, 2016, Volume 513, Number 1-2, Page 68
[14]
Bappaditya Chatterjee, Samah Hamed Almurisi, Ather Ahmed Mahdi Dukhan, Uttam Kumar Mandal, and Pinaki Sengupta
Drug Delivery, 2016, Volume 23, Number 9, Page 3639
[15]
Fiza Ur Rehman, Kifayat Ullah Shah, Shefaat Ullah Shah, Ikram Ullah Khan, Gul Majid Khan, and Amjad Khan
Expert Opinion on Drug Delivery, 2016, Page 1
[16]
Qiao Xing, Jia Song, Xiuhua You, Dongling Xu, Kexin Wang, Jiaqi Song, Qin Guo, Pengyu Li, Chuanbin Wu, and Haiyan Hu
International Journal of Pharmaceutics, 2016, Volume 511, Number 2, Page 709
[17]
Cedar H. A. Boakye, Ketan Patel, Apurva R. Patel, Henrique A. M. Faria, Valtencir Zucolotto, Stephen Safe, and Mandip Singh
Drug Delivery and Translational Research, 2016, Volume 6, Number 5, Page 526
[18]
Muhammad Ijaz, Sonja Bonengel, Ožbej Zupančič, Muhammad Yaqoob, Markus Hartl, Shah Hussain, Christian W. Huck, and Andreas Bernkop-Schnürch
Expert Opinion on Drug Delivery, 2016, Volume 13, Number 7, Page 923
[19]
Faiyaz Shakeel, Muzaffar Iqbal, and Essam Ezzeldin
Journal of Pharmacy and Pharmacology, 2016, Volume 68, Number 6, Page 772
[20]
Khaled Omer Aboalnaja, Soonham Yaghmoor, Taha Abdullah Kumosani, and David Julian McClements
Expert Opinion on Drug Delivery, 2016, Volume 13, Number 9, Page 1327
[21]
Waseem Kaialy and Maen Al Shafiee
Advances in Colloid and Interface Science, 2016, Volume 228, Page 71
[22]
Hang Zhao, Jiani Yuan, Qian Yang, Yanhua Xie, Wei Cao, and Siwang Wang
Journal of Agricultural and Food Chemistry, 2015, Volume 63, Number 28, Page 6386
[23]
Kazunori Iwanaga, Yoichi Higashiyama, Makoto Miyazaki, and Masawo Kakemi
Asian Journal of Pharmaceutical Sciences, 2015, Volume 10, Number 3, Page 186
[24]
Katja Čerpnjak, Alenka Zvonar, Franc Vrečer, and Mirjana Gašperlin
Drug Development and Industrial Pharmacy, 2015, Volume 41, Number 9, Page 1548
[25]
Irene Pereira de Sousa and Andreas Bernkop-Schnürch
Journal of Controlled Release, 2014, Volume 192, Page 301

Comments (0)

Please log in or register to comment.
Log in